Monthly Archives: May 2016

Johnny Mercer MP: “The Ministry of Defence has Betrayed Our Armed Forces’ Mental Health”

For many years, British service personnel have been treated with a controversial anti-malaria drug despite warnings issued by its manufacturer. The Commons defence select committee, of which I am a member, has heard from scientists, lawyers and servicemen to try … Continue reading

Posted in Advocacy, Media | Tagged , , , , , , , , , , | Leave a comment

British Parliamentary Inquiry: “Lariam Should be ‘Drug of Last Resort’ for Troops”

  Lariam, the anti-malarial drug sometimes prescribed to British troops, should be considered only as a drug of last resort, says the Defence Committee, in its report on the MoD’s use of the drug. Report: An acceptable risk? The use … Continue reading

Posted in Advocacy, Research | Tagged , , , , , , , , , | Leave a comment

British Army Medical Officer on Existing Treatments for Lariam Depression: “All They Do is Stick a Plaster Over It”

Maj Mick Wallace took Lariam during his deployment in Kenya in 1998, and he says he has been severely depressed ever since: “When I came back my wife said I wasn’t the same man. I was short-tempered, anxious at times. … Continue reading

Posted in Media, Our Stories | Tagged , , , , , , , , | Leave a comment

General Richards: “If the Use of Lariam is Banned it Would Not Be Before Time”

Kim Sengupta, British armed forces set to ban most prescriptions of controversial anti-malarial drug Lariam, The Independent, 23 May 2016. A number of senior officers say that recognition of the dangerous side-effects that the use of Lariam  is long overdue. General … Continue reading

Posted in Advocacy, Media | Tagged , , , , , , , , , | Leave a comment

Scientific Misconduct in the Australian Army Malaria Institute’s Clinical Trials of Tafenoquine – Part 1

The New Mefloquine? Mefloquine is now well known to be neurotoxic, one of several synthetic quinolines able to cause acute psychotic reactions and/or a chronic central nervous system (CNS) toxicity syndrome in a significant proportion of people given these drugs … Continue reading

Posted in Clinical Drug Trials, Media, Research | Tagged , , , , , , , , , | 2 Comments

Congressman John Carter Proposes Support for Mefloquine Veterans by the U.S. Defense Centers of Excellence

The National Defense Authorization Act for Fiscal Year 2017 is currently being debated in U.S. Congress. During this debate Congressman John Carter (Texas) has proposed additional controls on the use of mefloquine by the Department of Defense, and expanding the Defense Centers … Continue reading

Posted in Advocacy, Research, Support | Tagged , , , , , , | Leave a comment

Association of the U.S. Navy: Policy Position on Mefloquine Toxicity

This is the Association of the United States Navy’s policy position on mefloquine toxicity, included in written testimony for the record to a recent Joint Hearing of the House and Senate Veterans’ Affairs Committee. Written Testimony for the Record by … Continue reading

Posted in Advocacy, Support | Tagged , , , , , , | 1 Comment

Seroxat Study 329 Opens The Pandora’s Box For All Bogus Anti-Depressant Studies…. — GSK : Licence To (K) ill (Documenting GSK And Seroxat)

http://www.madinamerica.com/2016/05/researchers-deconstruct-ghostwritten-industry-trial-for-antidepressant/ Interview: Researchers Deconstruct Ghostwritten Industry Trial for Antidepressant In The News May 14, 2016 Researchers, Jon Jureidini, Jay Amsterdam and Leemon McHenry, have taken a closer look at the data from a randomized control trial of citalopram (Celexa) that … Continue reading

Posted in Clinical Drug Trials | Tagged , , , | 1 Comment

Featured Research (2004) – G. S. Dow et al, The Antimalarial Potential of 4-Quinolinecarbinolamines May be Limited Due to Neurotoxicity and Cross-resistance in Mefloquine-resistant P Falciparum Strains

The clinical potential of mefloquine has been compromised by reports of adverse neurological effects. A series of 4-quinolinecarbinolamines were compared in terms of neurotoxicity and antimalarial activity in an attempt to identify replacement drugs.   Neurotoxicity (MTT [thiazolyl blue reduction] … Continue reading

Posted in Research | Tagged , , , , | Leave a comment